Skip to main content

Regulatory action involving two doctors - social media posts (gender affirming care)

View on aph.gov.au (opens in a new tab)
Status: Answered, finished
Asked by: Senator Malcolm Roberts
Portfolio: Australian Health Practitioner Regulation Agency
Agency: Australian Health Practitioner Regulation Agency
Round: 2026-27 Budget estimates
Question No: Ahpra-2026.004
Asked: 2 June 2026
Answer due: 23 July 2026

Question

Senator ROBERTS: We've had this topic but not this question. Another complaint was that, in a post exchange, Dr Amos used biological pronouns and thereby was accused of misgendering a UK trans activist. The immediate action order used by Ahpra against Dr Amos is meant to be reserved, as I understand it, for when there is a reasonable belief that a health practitioner poses a serious risk to public health and safety. What specific elements of those posts did the board determine posed a serious risk to public health and safety under the so-called national law? Mr Untersteiner: As the chair has highlighted, I've answered this question numerous times. My response will remain. I can't comment on individual cases, because we have very clear confidentiality provisions. Senator ROBERTS: Let's move on then. Does a health practitioner have the right to refer- ACTING CHAIR: Senator Roberts, just one moment. I hope it is a point of order, Senator Henderson, and not commentary. Senator HENDERSON: No, of course not. This is just a point of order in relation to advice that I've just received through the secretariat. If the information is public, there's no basis not to answer these questions. We've checked the advice with the chair. So I would just challenge- ACTING CHAIR: You haven't checked the advice with the chair. Senator HENDERSON: Sorry, I meant with the secretary. Apologies. I'm just saying through the chair that I don't think it's appropriate that you decline to answer these questions. It's not consistent with the rules of the Senate insofar as- Mr Untersteiner: Sorry, to confirm- ACTING CHAIR: I think this is an interpretation issue. The information that that you have is not necessarily the stuff that is printed in whatever publication it is that has been quoted. There is a big difference in reporting from wherever you got it and the agencies actually providing you with their detailed private information that is protecting other people's privacy. But I'm happy for Mr Untersteiner to take that on notice and provide the rationale and the breakdown. Perhaps you, Senator Henderson, could provide the information that you were reading from previously in terms of your- Senator HENDERSON: I've tabled that, Chair. That's been tabled. ACTING CHAIR: Right. I still haven't seen it. Nobody's given it to me, I'm afraid. Senator HENDERSON: Please speak to the secretary. Please don't- Senator Roberts interjecting- ACTING CHAIR: I'll just finish. I believe you've been asking the Clerk about a public interest immunity claim, and we can go to that point at that time. But let's just take it on notice and come back with the rationale and the understanding, and then Senator Henderson and Senator Roberts can go through that and determine what steps they might like to take next. ... Senator ROBERTS: How can a doctor fulfil their ethical obligation to inform the public of potential harms of gender interventions and gender ideology without being accused of discrimination against LGBTIQA+ people? Mr Untersteiner: I've answered this question several times. As a regulator, we think health practitioners have a right to have public debate about a range of different issues, which include, again, gender-affirming treatment, gender blockers and other like treatments. We would not be taking regulatory action on that basis. Again, I think I've got to be very careful here about selective media and about using that as the basis. Senator ROBERTS: What specifically would Ahpra consider to be misinformation in a post? If you can't speak to that now, take it on notice. Mr Untersteiner: Sure.

Answer

Please find attached answer.

Comments · 0

Loading...

Loading comments...